South Africa is suspending its rollout of the Oxford/AstraZeneca coronavirus vaccine after findings suggested it offers limited protection against mild disease caused by the COVID-19 variant discovered there.
South Africa is suspending its rollout of the Oxford/AstraZeneca coronavirus vaccine after findings suggested it offers limited protection against mild disease caused by the COVID-19 variant discovered there.